Background illustration for clinical trials search

Paid Clinical Trials Cincinnati

Discover 1,164 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

for
Breast Cancer, TNBC - Triple-Negative Breast Cancer,
Location: Cincinnati OH, Goshen IN, Ann Arbor MI, Nashville TN,
Sponsor: Tempus AI

Sex: All

Age: 18 - 70+

Code: NCT07211178

Recruiting

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

for
Major Depressive Disorder
Location: Cincinnati OH, Columbus OH, Avon Lake OH, O'Fallon MO,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 18 - 65

Code: NCT05850689

Phase3, Recruiting

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

for
Melanoma (Skin Cancer),
Location: Cincinnati OH, Detroit MI, Nashville TN, Madison WI,
Sponsor: Aminex Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07287917

Phase1, Phase2, Recruiting

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

for
Pulmonary Arterial Hypertension
Location: Cincinnati OH, Louisville KY, Ann Arbor MI, Chicago IL,
Sponsor: Gossamer Bio USA, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06274801

Phase3, Recruiting

Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma

for
Oropharyngeal Squamous Cell Carcinoma,
Location: Cincinnati OH
Sponsor: Sara Medek

Sex: All

Age: 18+

Code: NCT07497607

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

for
Ovarian Neoplasms, Ovarian Cancer
Location: Cincinnati OH, Indianapolis IN, Fort Wayne IN,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07318558

Phase3, Recruiting

Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation

for
Radiation Injuries
Location: Cincinnati OH
Sponsor: University of Cincinnati

Sex: All

Age: 18+

Code: NCT07231588

Early_phase1, Recruiting

Promoting Immunotherapy Efficacy With Low-Dose Liver RT

for
Low-Dose Liver Radiation (LD-LRT), Non Small Cell Lung Cancer,
Location: Cincinnati OH
Sponsor: Jordan Kharofa

Sex: All

Age: 18+

Code: NCT07225036

Recruiting

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Location: Cincinnati OH, Evanston IL, Grand Rapids MI,
Sponsor: Genmab

Sex: Female

Age: 18+

Code: NCT07166094

Phase3, Recruiting

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

for
Intracerebral Hemorrhage
Location: Cincinnati OH, Columbus OH, Detroit MI, Chicago IL,
Sponsor: Joseph Broderick, MD

Sex: All

Age: 18 - 70+

Code: NCT07227246

Phase3, Recruiting

Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial

for
Metastatic Bone Disease
Location: Cincinnati OH, Fort Wayne IN, Aurora CO, Portland OR
Sponsor: Michelle Ghert, MD

Sex: All

Age: 18+

Code: NCT06863129

Recruiting

Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks

for
Mastectomy; Lymphedema, Breast Cancer
Location: Cincinnati OH
Sponsor: University of Cincinnati

Sex: All

Age: 18+

Code: NCT06574022

Recruiting

A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Cincinnati OH, Cleveland OH, Detroit MI, Durham NC,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06859762

Phase1, Recruiting

Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma

for
Head and Neck Cancer,
Location: Cincinnati OH
Sponsor: University of Cincinnati

Sex: All

Age: 18+

Code: NCT07213934

Phase1, Phase2, Recruiting

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

for
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Location: Cincinnati OH, North Canton OH, St Louis MO, Decatur GA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 65

Code: NCT06951711

Phase3, Recruiting

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

for
Multiple Sclerosis Spasticity
Location: Cincinnati OH, Columbus OH, Knoxville TN, Southfield MI,
Sponsor: Celgene

Sex: All

Age: 18 - 70

Code: NCT06782490

Phase2, Recruiting

LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This

for
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,
Location: Cincinnati OH
Sponsor: Zulfa Omer

Sex: All

Age: 18+

Code: NCT06978088

Phase2, Recruiting

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

for
Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma
Location: Cincinnati OH, Columbus OH, Greensboro NC,
Sponsor: UroGen Pharma Ltd.

Sex: All

Age: 18+

Code: NCT06774131

Phase3, Recruiting

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

for
Lymphoma, Large B-Cell, Diffuse
Location: Cincinnati OH, Edgewood KY, Lexington KY, Louisville KY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06890884

Phase2, Recruiting

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

for
Relapsing Multiple Sclerosis
Location: Cincinnati OH, Centerville OH, Columbus OH,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 40 - 70

Code: NCT06846281

Phase3, Recruiting